Antimicrobial Drugs: Principles, Mechanisms, and Resistance

Antimicrobial Drugs: Principles and Overview

Introduction to Antimicrobial Drugs

Antimicrobial drugs are chemical agents used to kill or inhibit the growth of microorganisms, thereby preventing or treating infectious diseases. These drugs have revolutionized modern medicine by significantly reducing mortality from infections that were once often fatal.

• Antimicrobial drug: Any substance that interferes with the growth and survival of microbes, including bacteria, viruses, fungi, and parasites.

• Antibiotic: A type of antimicrobial specifically targeting bacteria.

• Antimicrobials are classified by the type of pathogen they target: antibacterial, antiviral, antifungal, and antiparasitic agents.

Historical Perspective and Discovery of Penicillin

Before the advent of antimicrobial drugs, even minor infections could be fatal. The discovery of penicillin by Alexander Fleming in 1928 marked the beginning of the antibiotic era.

• Fleming observed that a mold, later identified as Penicillium, inhibited the growth of Staphylococcus aureus on a culture plate.

• This led to the development and mass production of penicillin, the first clinically used antibiotic.

Classification by Spectrum of Activity

Antimicrobial drugs are categorized based on the range of microbes they affect:

• Broad-spectrum: Effective against a wide variety of microbes; useful for empiric therapy but may disrupt normal microbiota and promote superinfections.

• Narrow-spectrum: Target a limited group of microbes; preferred when the pathogen is identified to minimize collateral damage.

• Limited-spectrum: Effective against a single organism or disease.

Empiric therapy involves starting treatment with a broad-spectrum drug before the pathogen is definitively identified, then switching to a narrow-spectrum agent once results are available.

Sources and Modification of Antimicrobial Drugs

Antimicrobials can be:

• Naturally occurring: Produced by microorganisms (e.g., penicillin from Penicillium species).

• Synthetic: Manufactured entirely by chemical processes.

• Semisynthetic: Chemically modified derivatives of natural antibiotics to improve efficacy, spectrum, or pharmacokinetics.

Drug modifications (e.g., adding R groups) can expand the spectrum, increase stability, and overcome resistance.

Pharmacological Principles of Antimicrobial Drugs

Selective Toxicity and Therapeutic Index

The ideal antimicrobial drug exhibits selective toxicity, meaning it targets microbial processes or structures not found in the host, minimizing harm to the patient.

• Therapeutic Index (TI): The ratio of the toxic dose to the therapeutic (effective) dose. A higher TI indicates a safer drug.

$\text{Therapeutic\ Index} = \frac{\text{Toxic\ Dose}}{\text{Therapeutic\ Dose}}$

Toxicity Considerations

Some antimicrobials can cause toxicity to key organs:

• Hepatotoxicity: Liver toxicity

• Nephrotoxicity: Kidney toxicity

• Gut microbiome toxicity: Disruption of normal intestinal flora

Example: Bacitracin is effective topically but is highly toxic if administered systemically.

Routes of Administration

• Oral: Preferred for convenience and cost; drug must be stable in the stomach and absorbed in the intestines.

• Parenteral: Non-oral routes (e.g., intravenous, intramuscular, subcutaneous, intradermal) allow rapid drug delivery but require injections.

Drug Stability and Half-Life

The half-life of a drug is the time required for half of the drug to be eliminated from the body. It determines dosing frequency and duration of action.

Drug Interactions and Contraindications

Antimicrobials may interact with other drugs, foods, or supplements, potentially altering their effectiveness or causing adverse effects.

Mechanisms and Targets of Antimicrobial Action

Antibacterial Drug Mechanisms

Antibacterial drugs exploit differences between prokaryotic and eukaryotic cells. Major targets include:

• Cell wall synthesis (e.g., beta-lactams like penicillins, cephalosporins)

• Protein synthesis (e.g., tetracyclines, macrolides)

• Nucleic acid synthesis (e.g., quinolones, rifamycins)

• Cell membrane integrity (e.g., polymyxins)

• Metabolic pathways (e.g., sulfa drugs, trimethoprim)

Bacteriostatic vs. Bactericidal Drugs

• Bacteriostatic: Inhibit bacterial growth; rely on the host immune system to clear infection.

• Bactericidal: Kill bacteria directly; useful in immunocompromised patients or severe infections.

CATEGORY	BACTERICIDAL	BACTERIOSTATIC
Definition	Substance that kills bacteria	Substance that inhibits bacterial growth
Minimum Concentration	MBC (minimum bactericidal concentration)	MIC (minimum inhibitory concentration)
Number of Bacterial Cells	Number decreases	Number remains the same
Viability of Bacteria	Bacteria die	Bacteria remain viable
Activation of Immune System	No effect	Helps immune system
High Dose Effect	Kills all bacterial cells	May act as bactericidal at high doses
Low Dose Effect	May act as bacteriostatic	May not be effective
Reversibility	Irreversible	Reversible

Antiviral, Antifungal, and Antiparasitic Drugs

• Antiviral drugs: Target steps in viral replication (attachment, penetration, uncoating, replication, assembly, release) or stimulate host immune responses. Most effective against actively replicating viruses.

• Antifungal drugs: Target fungal-specific structures such as ergosterol in cell membranes, cell wall synthesis, or nucleic acid synthesis. Toxicity is a concern due to similarities with host cells.

• Antiparasitic drugs: Target unique aspects of protozoan or helminth biology, but development is challenging due to complex life cycles and host similarities.

Assessing Sensitivity to Antimicrobial Drugs

Antibiotic Susceptibility Testing (AST)

AST determines which antimicrobials are effective against a specific pathogen. Common methods include:

• Kirby-Bauer disk diffusion: Measures zones of inhibition around antibiotic disks on agar plates to determine susceptibility.

• E-test (Epsilometer test): Uses strips with a gradient of antibiotic concentration to determine the minimum inhibitory concentration (MIC).

• Broth dilution tests: Serial dilutions of antibiotics in broth to determine MIC and minimum bactericidal concentration (MBC).

MIC: Lowest concentration of drug that inhibits visible growth. MBC: Lowest concentration that kills 99.9% of the initial inoculum.

Antimicrobial Drug Resistance and Stewardship

Antimicrobial Resistance (AMR)

AMR occurs when microbes are no longer affected by drugs that previously inhibited or killed them. This is a growing global health threat, driven by overuse and misuse of antimicrobials.

• Intrinsic resistance: Natural, due to inherent structural or functional characteristics (e.g., lack of target, impermeable cell wall).

• Acquired resistance: Due to genetic mutations or horizontal gene transfer (conjugation, transformation, transduction).

Mechanisms of Acquired Resistance

• Alteration of drug target (e.g., mutation in binding site)

• Inactivation of drug (e.g., enzymatic degradation)

• Reduced drug concentration (e.g., decreased permeability, efflux pumps)

Superbugs and Superinfections

Superbugs are strains resistant to multiple antimicrobials. Superinfections occur when resistant organisms proliferate after normal microbiota are eliminated by broad-spectrum drugs.

Factors Promoting Resistance

• Noncompliance with prescribed regimens

• Inappropriate prescribing (e.g., antibiotics for viral infections)

• Agricultural use of antimicrobials

• Unregulated use in some countries

Antimicrobial Stewardship

Stewardship programs promote the appropriate use of antimicrobials to improve patient outcomes, reduce resistance, and decrease the spread of multidrug-resistant organisms. Key strategies include:

• Using narrow-spectrum drugs when possible

• Following proper dosing and duration

• Educating healthcare workers and patients

• Limiting unnecessary prescriptions

Summary Table: Types of Antimicrobial Therapy

Type of Therapy	Description
Prophylaxis	Antibiotics used to prevent infection
Empiric	Organism is unknown but syndrome is known
Pathogen-directed	Organism is known but susceptibility is unknown
Susceptibility-guided	Organism is known and susceptibility is known

Key Terms and Concepts

• Antimicrobial drug: Compound that kills or inhibits microbes

• Antibiotic: Antibacterial drug

• Spectrum of activity: Range of microbes affected

• Selective toxicity: Drug targets microbe, not host

• Therapeutic index: Safety margin of a drug

• Bacteriostatic: Inhibits growth

• Bactericidal: Kills bacteria

• MIC/MBC: Minimum inhibitory/bactericidal concentration

• AMR: Antimicrobial resistance

• Superinfection: Secondary infection by resistant microbes

• Antimicrobial stewardship: Responsible use of antimicrobials